Abeler, V. M., Røyne, O., Thoresen, S., Danielsen, H. E., Nesland, J. M., & Kristensen, G. B. (2009). Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology, 54(3), 355-364.

Acem, I., van Houdt, W. J., Grünhagen, D. J., van der Graaf, W. T. A., Rueten-Budde, A. J., Gelderblom, H., . . . van de Sande, M. A. J. (2022). The role of perioperative chemotherapy in primary high-grade extremity soft tissue sarcoma: a risk-stratified analysis using PERSARC. European Journal of Cancer, 165, 71-80. https://doi.org/10.1016/j.ejca.2022.01.013

Aisen, A. M., Martel, W., Braunstein, E. M., McMillin, K. I., Phillips, W. A., & Kling, T. F. (1986). MRI and CT evaluation of primary bone and soft-tissue tumors. AJR. American journal of roentgenology, 146(4), 749-756.

Aksnes, L. H. (2008). Health in long-term survivors of bone sarcoma (Doktorgrad). Oslo: Faculty of Medicine, University of Oslo Unipub.

Al-Absi, E., Farrokhyar, F., Sharma, R., Whelan, K., Corbett, T., Patel, M., & Ghert, M. (2010). A systematic review and meta-analysis of oncologic outcomes of pre- versus postoperative radiation in localized resectable soft-tissue sarcoma. Annals of Surgical Oncology, 17(5), 1367-1374.

Albertsmeier, M., Rauch, A., Roeder, F., Hasenhütl, S., Pratschke, S., Kirschneck, M., . . . Angele, M. K. (2018). External Beam Radiation Therapy for Resectable Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis. Annals of Surgical Oncology, 25(3), 754-767. https://doi.org/10.1245/s10434-017-6081-2

Alektiar, K. M., Brennan, M. F., Healey, J. H., & Singer, S. (2008). Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity. Journal of Clinical Oncology, 26(20), 3440-3444.

Alektiar, K. M., Velasco, J., Zelefsky, M. J., Woodruff, J. M., Lewis, J. J., & Brennan, M. F. (2000). Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity. International Journal of Radiation Oncology, Biology, Physics, 48(4), 1051-1058.

Allen, A. M., Pawlicki, T., Dong, L., Fourkal, E., Buyyounouski, M., Cengel, K., . . . Konski, A. A. (2012). An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 103(1), 8-11. https://doi.org/10.1016/j.radonc.2012.02.001

Allen, D., & Cameron, R. (red.). (2017). Histopathology Specimens: Clinical, Pathological and Laboratory Aspects (3. utg.). Cham: Springer.

Alyas, F., James, S. L., Davies, A. M., & Saifuddin, A. (2007). The role of MR imaging in the diagnostic characterisation of appendicular bone tumours and tumour-like conditions. European Radiology, 17(10), 2675-2686.

Andreassen, A., Øyjord, T., Hovig, E., Holm, R., Flørenes, V. A., Nesland, J. M., . . . Børresen, A. L. (1993). p53 abnormalities in different subtypes of human sarcomas. Cancer Research, 53(3), 468-471.

Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., . . . Preiser, J. C. (2017). ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition, 36(1), 11-48. https://doi.org/10.1016/j.clnu.2016.07.015

Arlen, M., Higinbotham, N. L., Huvos, A. G., Marcove, R. C., Miller, T., & Shah, I. C. (1971). Radiation-induced sarcoma of bone. Cancer, 28(5), 1087-1099.

Bauer, H. C., Trovik, C. S., Alvegard, T. A., Berlin, O., Erlanson, M., Gustafson, P., . . . Wiklund, T. (2001). Monitoring referral and treatment in soft tissue sarcoma: study based on 1,851 patients from the Scandinavian Sarcoma Group Register. Acta Orthopaedica Scandinavica, 72(2), 150-159.

Beane, J. D., Yang, J. C., White, D., Steinberg, S. M., Rosenberg, S. A., & Rudloff, U. (2014). Efficacy of adjuvant radiation therapy in the treatment of soft tissue sarcoma of the extremity: 20-year follow-up of a randomized prospective trial. Annals of Surgical Oncology, 21(8), 2484-2489. https://doi.org/10.1245/s10434-014-3732-4

Becher, S., & Oskouei, S. (2015). PET Imaging in Sarcoma. The Orthopedic clinics of North America, 46(3), 409-415, xi. https://doi.org/10.1016/j.ocl.2015.03.001

Berger-Richardson, D., & Swallow, C. J. (2017). Needle tract seeding after percutaneous biopsy of sarcoma: Risk/benefit considerations. Cancer, 123(4), 560-567. https://doi.org/10.1002/cncr.30370

Berndsen, M., Renberg, S., Hølmebakk, T., Hancke, E., Puls, F., Karlsson, F., . . . Lindskog, S. (2023). Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapy. The British journal of surgery, 110(12), 1857-1862. https://doi.org/10.1093/bjs/znad309

Berner, K., Johannesen, T. B., Berner, A., Haugland, H. K., Bjerkehagen, B., Bøhler, P. J., & Bruland, O. S. (2015). Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma. Acta Oncologica, 54(1), 25-33.

Berquist, T. H., Ehman, R. L., King, B. F., Hodgman, C. G., & Ilstrup, D. M. (1990). Value of MR imaging in differentiating benign from malignant soft-tissue masses: study of 95 lesions. AJR. American journal of roentgenology, 155(6), 1251-1255.

Bhangu, A. A., Beard, J. A., & Grimer, R. J. (2004). Should soft tissue sarcomas be treated at a specialist centre? Sarcoma, 8(1), 1-6.

Bielack, S. S., & Carrle, D. (2008). State-of-the-art approach in selective curable tumors: bone sarcoma. Annals of oncology, 19 Suppl 7, vii155-vii160.

Bielack, S. S., Smeland, S., Whelan, J. S., Marina, N., Jovic, G., Hook, J. M., . . . Euramos- investigators. (2015). Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial. Journal of Clinical Oncology, 33(20), 2279-2287.

Bischof, D. A., Kim, Y., Dodson, R., Jimenez, M. C., Behman, R., Cocieru, A., . . . Pawlik, T. M. (2015). Conditional disease-free survival after surgical resection of gastrointestinal stromal tumors: a multi-institutional analysis of 502 patients. JAMA surgery, 150(4), 299-306. https://doi.org/10.1001/jamasurg.2014.2881

Bjerkehagen, B., Smeland, S., Walberg, L., Skjeldal, S., Hall, K. S., Nesland, J. M., . . . Saeter, G. (2008). Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital. Acta Oncologica, 47(8), 1475-1482.

Bjerkehagen, B., Småstuen, M. C., Hall, K. S., Skjeldal, S., Smeland, S., & Fosså, S. D. (2012). Why do patients with radiation-induced sarcomas have a poor sarcoma-related survival? British Journal of Cancer, 106(2), 297-306. https://doi.org/10.1038/bjc.2011.559

Blanchard, D. K., Reynolds, C., Grant, C. S., Farley, D. R., & Donohue, J. H. (2002). Radiation-induced breast sarcoma. American Journal of Surgery, 184(4), 356-358.

Blay, J. Y., Serrano, C., Heinrich, M. C., Zalcberg, J., Bauer, S., Gelderblom, H., . . . von Mehren, M. (2020). Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Oncology, 21(7), 923-934. https://doi.org/10.1016/s1470-2045(20)30168-6

Bonvalot, S., Gronchi, A., Le Péchoux, C., Swallow, C. J., Strauss, D., Meeus, P., . . . Haas, R. L. (2020). Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncology, 21(10), 1366-1377. https://doi.org/10.1016/s1470-2045(20)30446-0

Bonvalot, S., Rivoire, M., Castaing, M., Stoeckle, E., Le Cesne, A., Blay, J. Y., & Laplanche, A. (2009). Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. Journal of Clinical Oncology, 27(1), 31-37. https://doi.org/10.1200/jco.2008.18.0802

Bosma, S. E., Cleven, A. H. G., & Dijkstra, P. D. S. (2019). Can Navigation Improve the Ability to Achieve Tumor-free Margins in Pelvic and Sacral Primary Bone Sarcoma Resections? A Historically Controlled Study. Clinical Orthopaedics and Related Research, 477(7), 1548-1559. https://doi.org/10.1097/corr.0000000000000766

Boye, K., Del Prever, A. B., Eriksson, M., Saeter, G., Tienghi, A., Lindholm, P., . . . Hall, K. S. (2014). High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study. Pediatric blood & cancer, 61(5), 840-845. https://doi.org/10.1002/pbc.24868

Brennan, M. F., Antonescu, C. R., Moraco, N., & Singer, S. (2014). Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Annals of Surgery, 260(3), 416-421; discussion 421-412. https://doi.org/10.1097/sla.0000000000000869

Brenner, D. J., Curtis, R. E., Hall, E. J., & Ron, E. (2000). Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery. Cancer, 88(2), 398-406.

Cahan, W. G., Woodard, H. Q., Higinbotham, N. L., Stewart, F. W., & Coley, B. L. (1998). Sarcoma arising in irradiated bone: report of eleven cases. 1948. Cancer, 82(1), 8-34.

Callegaro, D., Barretta, F., Raut, C. P., Johnston, W., Strauss, D. C., Honoré, C., . . . Gronchi, A. (2023). New Sarculator Prognostic Nomograms for Patients with Primary Retroperitoneal Sarcoma: Case Volume Does Matter. Annals of Surgery. https://doi.org/10.1097/sla.0000000000006098

Callegaro, D., Miceli, R., Bonvalot, S., Ferguson, P., Strauss, D. C., Levy, A., . . . Gronchi, A. (2016). Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. Lancet Oncology, 17(5), 671-680. https://doi.org/10.1016/s1470-2045(16)00010-3

Canter, R. J., Qin, L. X., Ferrone, C. R., Maki, R. G., Singer, S., & Brennan, M. F. (2008). Why do patients with low-grade soft tissue sarcoma die? Annals of Surgical Oncology, 15(12), 3550-3560.

Casali, P. G., Blay, J. Y., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., . . . Stacchiotti, S. (2022). Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 33(1), 20-33. https://doi.org/10.1016/j.annonc.2021.09.005

Cha, C., Antonescu, C. R., Quan, M. L., Maru, S., & Brennan, M. F. (2004). Long-term results with resection of radiation-induced soft tissue sarcomas. Annals of Surgery, 239(6), 903-909.

Chen, L., Wu, X., Ma, X., Guo, L., Zhu, C., & Li, Q. (2017). Prognostic value of 18F-FDG PET-CT-based functional parameters in patients with soft tissue sarcoma: A meta-analysis. Medicine (Baltimore), 96(6), e5913. https://doi.org/10.1097/md.0000000000005913

Chouliaras, K., Senehi, R., Ethun, C. G., Poultsides, G., Grignol, V., Clarke, C. N., . . . Votanopoulos, K. I. (2019). Role of radiation therapy for retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative. Journal of surgical oncology, 120(7), 1227-1234. https://doi.org/10.1002/jso.25694

Ciernik, I. F., Niemierko, A., Harmon, D. C., Kobayashi, W., Chen, Y. L., Yock, T. I., . . . Delaney, T. F. (2011). Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma. Cancer, 117(19), 4522-4530. https://doi.org/10.1002/cncr.26037

Coindre, J. M. (2006). Grading of soft tissue sarcomas: review and update. Archives of Pathology and Laboratory Medicine, 130(10), 1448-1453. https://doi.org/10.5858/2006-130-1448-gostsr

Constantinidou, A., Jones, R. L., Olmos, D., Thway, K., Fisher, C., Al-Muderis, O., & Judson, I. (2012). Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour. Acta Oncologica, 51(4), 550-554. https://doi.org/10.3109/0284186x.2011.626450

Cramp, F., & Daniel, J. (2008). Exercise for the management of cancer-related fatigue in adults. The Cochrane database of systematic reviews, (2), CD006145.

D'Ambrosio, L., Touati, N., Blay, J. Y., Grignani, G., Flippot, R., Czarnecka, A. M., . . . Gronchi, A. (2020). Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Cancer, 126(11), 2637-2647. https://doi.org/10.1002/cncr.32795

D'Angelo, S. P., Mahoney, M. R., Van Tine, B. A., Atkins, J., Milhem, M. M., Jahagirdar, B. N., . . . Streicher, H. (2018). Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials. Lancet Oncology, 19(3), 416-426. https://doi.org/10.1016/s1470-2045(18)30006-8

Daisne, J. F., Duprez, T., Weynand, B., Lonneux, M., Hamoir, M., Reychler, H., & Gregoire, V. (2004). Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology, 233(1), 93-100.

Dangoor, A., Seddon, B., Gerrand, C., Grimer, R., Whelan, J., & Judson, I. (2016). UK guidelines for the management of soft tissue sarcomas. Clinical sarcoma research, 6, 20. https://doi.org/10.1186/s13569-016-0060-4

Davis, A. M., O'Sullivan, B., Turcotte, R., Bell, R., Catton, C., Chabot, P., . . . N. C. I. Canada Clinical Trial Group Randomized Trial. (2005). Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 75(1), 48-53.

Davis, L. E., Bolejack, V., Ryan, C. W., Ganjoo, K. N., Loggers, E. T., Chawla, S., . . . Maki, R. G. (2019). Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma. Journal of Clinical Oncology, 37(16), 1424-1431. https://doi.org/10.1200/jco.18.02374

DeMatteo, R. P., Lewis, J. J., Leung, D., Mudan, S. S., Woodruff, J. M., & Brennan, M. F. (2000). Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Annals of Surgery, 231(1), 51-58.

Demetri, G. D., Reichardt, P., Kang, Y. K., Blay, J. Y., Rutkowski, P., Gelderblom, H., . . . Casali, P. G. (2013). Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet, 381(9863), 295-302. https://doi.org/10.1016/s0140-6736(12)61857-1

Demetri, G. D., Schöffski, P., Grignani, G., Blay, J. Y., Maki, R. G., Van Tine, B. A., . . . Chawla, S. (2017). Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine. Journal of Clinical Oncology, 35(30), 3433-3439. https://doi.org/10.1200/jco.2016.71.6605

Demetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., . . . Casali, P. G. (2006). Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet, 368(9544), 1329-1338.

Demetri, G. D., von Mehren, M., Jones, R. L., Hensley, M. L., Schuetze, S. M., Staddon, A., . . . Patel, S. R. (2016). Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial. Journal of Clinical Oncology, 34(8), 786-793. https://doi.org/10.1200/jco.2015.62.4734

Demizu, Y., Jin, D., Sulaiman, N. S., Nagano, F., Terashima, K., Tokumaru, S., . . . Okimoto, T. (2017). Particle Therapy Using Protons or Carbon Ions for Unresectable or Incompletely Resected Bone and Soft Tissue Sarcomas of the Pelvis. International Journal of Radiation Oncology, Biology, Physics, 98(2), 367-374.

Di Brina, L., Fogliata, A., Navarria, P., D'Agostino, G., Franzese, C., Franceschini, D., . . . Scorsetti, M. (2019). Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation. The British journal of radiology, 92(1102), 20190252. https://doi.org/10.1259/bjr.20190252

Dickie, C. I., Haas, R., & O'Sullivan, B. (2015). Adjuvant radiation for soft tissue sarcomas. American Society of Clinical Oncology educational book, e634-642. https://doi.org/10.14694/EdBook_AM.2015.35.e634

Dirksen, U., Brennan, B., Le Deley, M. C., Cozic, N., van den Berg, H., Bhadri, V., . . . Hawkins, D. S. (2019). High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008. Journal of Clinical Oncology, 37(34), 3192-3202. https://doi.org/10.1200/jco.19.00915

DuBois, S. G., Krailo, M. D., Gebhardt, M. C., Donaldson, S. S., Marcus, K. J., Dormans, J., . . . Grier, H. E. (2015). Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology Group. Cancer, 121(3), 467-475. https://doi.org/10.1002/cncr.29065

Duffaud, F., Mir, O., Boudou-Rouquette, P., Piperno-Neumann, S., Penel, N., Bompas, E., . . . Blay, J. Y. (2019). Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study. Lancet Oncology, 20(1), 120-133. https://doi.org/10.1016/s1470-2045(18)30742-3

Dyrop, H. B., Vedsted, P., Safwat, A., Maretty-Nielsen, K., Hansen, B. H., Jørgensen, P. H., . . . Keller, J. (2014). Alarm symptoms of soft-tissue and bone sarcoma in patients referred to a specialist center. Acta orthopaedica, 85(6), 657-662.

Eaton, B. R., Schwarz, R., Vatner, R., Yeh, B., Claude, L., Indelicato, D. J., & Laack, N. (2021). Osteosarcoma. Pediatric blood & cancer, 68(Suppl 2), e28352. https://doi.org/10.1002/pbc.28352

Eggermont, A. M., de Wilt, J. H., & ten Hagen, T. L. (2003). Current uses of isolated limb perfusion in the clinic and a model system for new strategies. Lancet Oncology, 4(7), 429-437.

Elvsaas, I.-K. Ø., Graff, B. A., Harboe, I., & Norderhaug, I. N. (2008). Kompresjonsstrømper i forebygging av dyp venetrombose (Rapport fra Kunnskapssenteret nr. 28). Oslo: Nasjonalt kunnskapsenter for helsetjenesten. Hentet fra https://www.fhi.no/publ/eldre/kompresjonsstromper-i-forebygging-av-dyp-venetrombose-/

Emami, B., Lyman, J., Brown, A., Coia, L., Goitein, M., Munzenrider, J. E., . . . Wesson, M. (1991). Tolerance of normal tissue to therapeutic irradiation. International Journal of Radiation Oncology, Biology, Physics, 21(1), 109-122.

Emile, J. F., Brahimi, S., Coindre, J. M., Bringuier, P. P., Monges, G., Samb, P., . . . Aegerter, P. (2012). Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs. Medical Oncology, 29(3), 1765-1772. https://doi.org/10.1007/s12032-011-0074-y

Eng, C., Li, F. P., Abramson, D. H., Ellsworth, R. M., Wong, F. L., Goldman, M. B., . . . Boice, J. D., Jr. (1993). Mortality from second tumors among long-term survivors of retinoblastoma. Journal of the National Cancer Institute, 85(14), 1121-1128.

Engström, K., Bergh, P., Cederlund, C. G., Hultborn, R., Willen, H., Aman, P., . . . Meis-Kindblom, J. M. (2007). Irradiation of myxoid/round cell liposarcoma induces volume reduction and lipoma-like morphology. Acta Oncologica, 46(6), 838-845. https://doi.org/10.1080/02841860601080415

Enneking, W. F., Spanier, S. S., & Goodman, M. A. (1980). A system for the surgical staging of musculoskeletal sarcoma. Clinical Orthopaedics and Related Research, (153), 106-120.

Eriksson, M. (2010). Histology-driven chemotherapy of soft-tissue sarcoma. Annals of oncology, 21(Suppl 7), vii270-276. https://doi.org/10.1093/annonc/mdq285

Eriksson, M., Reichardt, P., Sundby Hall, K., Schütte, J., Cameron, S., Hohenberger, P., . . . Joensuu, H. (2016). Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence? European Journal of Cancer, 59, 128-133. https://doi.org/10.1016/j.ejca.2016.02.021

European and American Osteosarcoma Study Group. (2012). Euramos 1. Randomised trial of the European and American osteosarcoma study group to optimise treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy. London: MRC Clinical Trials Unit. Hentet fra https://www.mrcctu.ucl.ac.uk/studies/all-studies/e/euramos-1/

Evrard, R., Schubert, T., Paul, L., & Docquier, P. L. (2019). Resection margins obtained with patient-specific instruments for resecting primary pelvic bone sarcomas: A case-control study. Orthopaedics & traumatology, surgery & research : OTSR, 105(4), 781-787. https://doi.org/10.1016/j.otsr.2018.12.016

FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma (FaR-RMS). (2020-2030). [pågående studie]. (NCT04625907). Hentet fra https://clinicaltrials.gov/ct2/show/NCT04625907

Fein, D. A., Lee, W. R., Lanciano, R. M., Corn, B. W., Herbert, S. H., Hanlon, A. L., . . . Coia, L. R. (1995). Management of extremity soft tissue sarcomas with limb-sparing surgery and postoperative irradiation: do total dose, overall treatment time, and the surgery-radiotherapy interval impact on local control? International Journal of Radiation Oncology, Biology, Physics, 32(4), 969-976.

Feinberg, L., Srinivasan, A., Singh, J. K., Parry, M., Stevenson, J., Jeys, L., . . . Desai, A. (2018). Impact of specialist management on survival from radiation-associated angiosarcoma of the breast. The British journal of surgery, 105(4), 401-409. https://doi.org/10.1002/bjs.10696

Fendler, W. P., Chalkidis, R. P., Ilhan, H., Knosel, T., Herrmann, K., Issels, R. D., . . . Hacker, M. (2015). Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrence. European Radiology, 25(8), 2214-2221. https://doi.org/10.1007/s00330-015-3654-y

Ferrari, A., van Noesel, M. M., Brennan, B., Zanetti, I., Corradini, N., Casanova, M., . . . Orbach, D. (2021). Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG). Lancet. Child & adolescent health, 5(8), 546-558. https://doi.org/10.1016/s2352-4642(21)00159-0

Ferrari, S., Bielack, S. S., Smeland, S., Longhi, A., Egerer, G., Sundby Hall, K., . . . Reichardt, P. (2018). EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma. Tumori, 104(1), 30-36. https://doi.org/10.5301/tj.5000696

Ferrari, S., Smeland, S., Mercuri, M., Bertoni, F., Longhi, A., Ruggieri, P., . . . Italian and Scandinavian Sarcoma Groups. (2005). Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. Journal of Clinical Oncology, 23(34), 8845-8852.

Ferrari, S., Sundby Hall, K., Luksch, R., Tienghi, A., Wiebe, T., Fagioli, F., . . . Smeland, S. (2011). Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol. Annals of Oncology, 22(5), 1221-1227.

Ferraro, D., & Zalcberg, J. (2014). Regorafenib in gastrointestinal stromal tumors: clinical evidence and place in therapy. Therapeutic advances in medical oncology, 6(5), 222-228. https://doi.org/10.1177/1758834014544892

Fletcher, C. D., Berman, J. J., Corless, C., Gorstein, F., Lasota, J., Longley, B. J., . . . Weiss, S. W. (2002). Diagnosis of gastrointestinal stromal tumors: a consensus approach. International Journal of Surgical Pathology, 10(2), 81-89.

Frustaci, S., Gherlinzoni, F., De, P. A., Bonetti, M., Azzarelli, A., Comandone, A., . . . Picci, P. (2001). Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. Journal of Clinical Oncology, 19(5), 1238-1247.

Fuglø, H. M., Jørgensen, S. M., Loft, A., Hovgaard, D., & Petersen, M. M. (2012). The diagnostic and prognostic value of (1)(8)F-FDG PET/CT in the initial assessment of high-grade bone and soft tissue sarcoma. A retrospective study of 89 patients. European journal of nuclear medicine and molecular imaging, 39(9), 1416-1424. https://doi.org/10.1007/s00259-012-2159-z

Gannon, N. P., King, D. M., Ethun, C. G., Charlson, J., Tran, T. B., Poultsides, G., . . . Bedi, M. (2019). The role of radiation therapy and margin width in localized soft-tissue sarcoma: Analysis from the US Sarcoma Collaborative. Journal of surgical oncology, 120(3), 325-331. https://doi.org/10.1002/jso.25522

Garcia del Muro, X. (2015). Nilotinib, imatinib, and GIST therapy. Lancet Oncology, 16(5), 483-484.

Gastrointestinal Stromal Tumor Meta-Analysis Group (MetaGIST). (2010). Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients. Journal of Clinical Oncology, 28(7), 1247-1253. https://doi.org/10.1200/jco.2009.24.2099

Georgiesh, T., Aggerholm-Pedersen, N., Schöffski, P., Zhang, Y., Napolitano, A., Bovée, J., . . . Boye, K. (2022). Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour. British Journal of Cancer, 127(10), 1793-1798. https://doi.org/10.1038/s41416-022-01959-4

Gerbers, J. G., Stevens, M., Ploegmakers, J. J., Bulstra, S. K., & Jutte, P. C. (2014). Computer-assisted surgery in orthopedic oncology. Acta orthopaedica, 85(6), 663-669.

Gerrand, C., Athanasou, N., Brennan, B., Grimer, R., Judson, I., Morland, B., . . . British Sarcoma Group. (2016). UK guidelines for the management of bone sarcomas. Clinical sarcoma research, 6, 7. https://doi.org/10.1186/s13569-016-0047-1

Gerrand, C. H., Bell, R. S., Wunder, J. S., Kandel, R. A., O'Sullivan, B., Catton, C. N., . . . Davis, A. M. (2003). The influence of anatomic location on outcome in patients with soft tissue sarcoma of the extremity. Cancer, 97(2), 485-492.

Gielen, J. L., De Schepper, A. M., Vanhoenacker, F., Parizel, P. M., Wang, X. L., Sciot, R., & Weyler, J. (2004). Accuracy of MRI in characterization of soft tissue tumors and tumor-like lesions. A prospective study in 548 patients. European Radiology, 14(12), 2320-2330.

Giraudet-Le Quintrec, J. S., Coste, J., Vastel, L., Pacault, V., Jeanne, L., Lamas, J. P., . . . Courpied, J. P. (2003). Positive effect of patient education for hip surgery: a randomized trial. Clinical Orthopaedics and Related Research, (414), 112-120.

Goldblum, J. R., Weiss, S. W., & Folpe, A. L. (2019). Enzinger and Weiss's soft tissue tumors (7. utg.). Philadelphia: Mosby Elsevier.

Gomarteli, K., Fleckenstein, J., Kirschner, S., Bobu, V., Brockmann, M. A., Henzler, T., . . . Giordano, F. A. (2019). Radiation-induced malignancies after intensity-modulated versus conventional mediastinal radiotherapy in a small animal model. Scientific Reports, 9(1), 15489. https://doi.org/10.1038/s41598-019-51735-3

Griffith, J. F., Yip, S. W. Y., Hung, E. H. Y., Fong, R. C. W., Leung, J., Ng, A. W. H., . . . Lee, R. K. L. (2020). Accuracy of ultrasound in the characterisation of deep soft tissue masses: a prospective study. European Radiology, 30(11), 5894-5903. https://doi.org/10.1007/s00330-020-07002-5

Grimer, R. J., Carter, S. R., Tillman, R. M., & Abudu, A. (2001). Early symptoms and diagnosis of bone tumors. The Journal of bone and joint surgery. American volume, 83-A(7), 1107-1108.

Grimer, R. J., & Sneath, R. S. (1990). Diagnosing malignant bone tumours. The Journal of bone and joint surgery. British volume, 72(5), 754-756.

Gronchi, A., Bonvalot, S., Poveda Velasco, A., Kotasek, D., Rutkowski, P., Hohenberger, P., . . . Casali, P. G. (2020a). Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib. JAMA surgery, 155(6), e200397. https://doi.org/10.1001/jamasurg.2020.0397

Gronchi, A., Lo Vullo, S., Fiore, M., Mussi, C., Stacchiotti, S., Collini, P., . . . Casali, P. G. (2009). Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. Journal of Clinical Oncology, 27(1), 24-30. https://doi.org/10.1200/jco.2008.17.8871

Gronchi, A., Miah, A. B., Dei Tos, A. P., Abecassis, N., Bajpai, J., Bauer, S., . . . Stacchiotti, S. (2021). Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up(☆). Annals of oncology, 32(11), 1348-1365. https://doi.org/10.1016/j.annonc.2021.07.006

Gronchi, A., Miceli, R., Allard, M. A., Callegaro, D., Le Péchoux, C., Fiore, M., . . . Bonvalot, S. (2015). Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection. Annals of Surgical Oncology, 22(5), 1447-1454. https://doi.org/10.1245/s10434-014-4130-7

Gronchi, A., Palmerini, E., Quagliuolo, V., Martin Broto, J., Lopez Pousa, A., Grignani, G., . . . Casali, P. G. (2020b). Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups. Journal of Clinical Oncology, 38(19), 2178-2186. https://doi.org/10.1200/jco.19.03289

Gronchi, A., Strauss, D. C., Miceli, R., Bonvalot, S., Swallow, C. J., Hohenberger, P., . . . Raut, C. P. (2016). Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group. Annals of Surgery, 263(5), 1002-1009. https://doi.org/10.1097/sla.0000000000001447

Grosso, F., Sanfilippo, R., Virdis, E., Piovesan, C., Collini, P., Dileo, P., . . . Casali, P. G. (2009). Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series. Annals of oncology, 20(8), 1439-1444.

Gustafson, P., Dreinhofer, K. E., & Rydholm, A. (1994). Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients. Acta Orthopaedica Scandinavica, 65(1), 47-50.

Gustafsson, U. O., Scott, M. J., Schwenk, W., Demartines, N., Roulin, D., Francis, N., . . . Ljungqvist, O. (2013). Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS()) Society recommendations. World Journal of Surgery, 37(2), 259-284.

Gyorki, D. E., & Brennan, M. F. (2014). Management of recurrent retroperitoneal sarcoma. Journal of surgical oncology, 109(1), 53-59. https://doi.org/10.1002/jso.23463

Habrand, J. L., Schneider, R., Alapetite, C., Feuvret, L., Petras, S., Datchary, J., . . . Sainte-Rose, C. (2008). Proton therapy in pediatric skull base and cervical canal low-grade bone malignancies. International Journal of Radiation Oncology, Biology, Physics, 71(3), 672-675. https://doi.org/10.1016/j.ijrobp.2008.02.043

Haibach, H., Farrell, C., & Dittrich, F. J. (1985). Neoplasms arising in Paget's disease of bone: a study of 82 cases. American Journal of Clinical Pathology, 83(5), 594-600.

Hall, K. S., Bruland Ø, S., Bjerkehagen, B., Lidbrink, E., Jebsen, N., Hagberg, H., . . . Eriksson, M. (2020). Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study. Clinical sarcoma research, 10(1), 22. https://doi.org/10.1186/s13569-020-00145-5

Hall, K. S., Bruland Ø, S., Bjerkehagen, B., Zaikova, O., Engellau, J., Hagberg, O., . . . Eriksson, M. (2018). Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors-A Scandinavian Sarcoma Group study (SSG XX). European Journal of Cancer, 99, 78-85. https://doi.org/10.1016/j.ejca.2018.05.011

Hardes, J., von Eiff, C., Streitbuerger, A., Balke, M., Budny, T., Henrichs, M. P., . . . Ahrens, H. (2010). Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. Journal of surgical oncology, 101(5), 389-395. https://doi.org/10.1002/jso.21498

Hartmann, J. T., Kopp, H. G., Gruenwald, V., Piperno-Neumann, S., Kunitz, A., Hofheinz, R., . . . Mayer, F. (2020). Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcoma. European Journal of Cancer, 124, 152-160. https://doi.org/10.1016/j.ejca.2019.10.016

Hawkins, M. M., Wilson, L. M., Burton, H. S., Potok, M. H., Winter, D. L., Marsden, H. B., & Stovall, M. A. (1996). Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer. Journal of the National Cancer Institute, 88(5), 270-278.

Helsedirektoratet. (2019). Nasjonalt handlingsprogram for palliasjon i kreftomsorgen: nasjonal faglig retningslinje (rev utg.). (IS-2800). Oslo: Helsedirektoratet. Hentet fra https://www.helsedirektoratet.no/retningslinjer/palliasjon-i-kreftomsorgen-handlingsprogram

Helsedirektoratet. (2020). Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av kreft hos barn: nasjonal faglig retningslinje (IS-2925). Oslo: Helsedirektoratet. Hentet fra https://www.helsedirektoratet.no/retningslinjer/kreft-hos-barn-handlingsprogram

Helsedirektoratet. (14. mars 2022). Forebygging og behandling av underernæring: nasjonal faglig retningslinje. [nettdokument]. Oslo: Helsedirektoratet. Hentet 03. juni 2024, fra https://www.helsedirektoratet.no/retningslinjer/forebygging-og-behandling-av-underernaering

Hensley, M. L., Maki, R., Venkatraman, E., Geller, G., Lovegren, M., Aghajanian, C., . . . Spriggs, D. R. (2002). Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. Journal of Clinical Oncology, 20(12), 2824-2831.

Heslin, M. J., Lewis, J. J., Nadler, E., Newman, E., Woodruff, J. M., Casper, E. S., . . . Brennan, M. F. (1997). Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. Journal of Clinical Oncology, 15(8), 2832-2839.

Higuchi, T., Yamamoto, N., Nishida, H., Hayashi, K., Takeuchi, A., Kimura, H., . . . Tsuchiya, H. (2017). Knee joint preservation surgery in osteosarcoma using tumour-bearing bone treated with liquid nitrogen. International orthopaedics, 41(10), 2189-2197. https://doi.org/10.1007/s00264-017-3499-x

Hompland, I., Ferrari, S., Bielack, S., Palmerini, E., Hall, K. S., Picci, P., . . . Smeland, S. (2021). Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study. European Journal of Cancer, 151, 150-158. https://doi.org/10.1016/j.ejca.2021.04.017

Hongtao, L., Hui, Z., Bingshun, W., Xiaojin, W., Zhiyu, W., Shuier, Z., . . . Yang, Y. (2012). 18F-FDG positron emission tomography for the assessment of histological response to neoadjuvant chemotherapy in osteosarcomas: a meta-analysis. Surgical Oncology, 21(4), e165-170. https://doi.org/10.1016/j.suronc.2012.07.002

Hough, A. (2001). Physiotherapy in respiratory care: an evidence-based approach to respiratory and cardiac management. Cheltenham: Trans-Atlantic Publications.

Huang, T., Li, F., Yan, Z., Ma, Y., Xiong, F., Cai, X., . . . Dong, J. (2018). Effectiveness of 18F-FDG PET/CT in the diagnosis, staging and recurrence monitoring of Ewing sarcoma family of tumors: A meta-analysis of 23 studies. Medicine (Baltimore), 97(48), e13457. https://doi.org/10.1097/MD.0000000000013457

Hug, E. B., Adams, J., Fitzek, M., De Vries, A., & Munzenrider, J. E. (2000). Fractionated, three-dimensional, planning-assisted proton-radiation therapy for orbital rhabdomyosarcoma: a novel technique. International Journal of Radiation Oncology, Biology, Physics, 47(4), 979-984.

Hung, E. H. Y., Griffith, J. F., Yip, S. W. Y., Ivory, M., Lee, J. C. H., Ng, A. W. H., & Tong, C. S. L. (2020). Accuracy of ultrasound in the characterization of superficial soft tissue tumors: a prospective study. Skeletal Radiology, 49(6), 883-892. https://doi.org/10.1007/s00256-019-03365-z

Hung, J., & Anderson, R. (1997). p53: functions, mutations and sarcomas. Acta orthopaedica Scandinavica Suppl, 273, 68-73.

Huvos, A. G., Butler, A., & Bretsky, S. S. (1983). Osteogenic sarcoma associated with Paget's disease of bone. A clinicopathologic study of 65 patients. Cancer, 52(8), 1489-1495.

Huvos, A. G., Sundaresan, N., Bretsky, S. S., & Butler, A. (1985). Osteogenic sarcoma of the skull. A clinicopathologic study of 19 patients. Cancer, 56(5), 1214-1221.

Hwang, J. P., Lim, I., Kong, C. B., Jeon, D. G., Byun, B. H., Kim, B. I., . . . Lim, S. M. (2016). Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma. PloS One, 11(4), e0153281. https://doi.org/10.1371/journal.pone.0153281

Hølmebakk, T., Bjerkehagen, B., Hompland, I., Stoldt, S., & Boye, K. (2019). Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour. The British journal of surgery, 106(4), 419-426. https://doi.org/10.1002/bjs.11027

Hølmebakk, T., Hompland, I., Bjerkehagen, B., Stoldt, S., Bruland Ø, S., Hall, K. S., & Boye, K. (2018). Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study. Annals of Surgical Oncology, 25(5), 1133-1139. https://doi.org/10.1245/s10434-018-6353-5

Hølmebakk, T., Wiedswang, A. M., Meza-Zepeda, L. A., Hompland, I., Lobmaier, I. V. K., Berner, J. M., . . . Boye, K. (2021). Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach. Annals of Surgical Oncology, 28(11), 6837-6845. https://doi.org/10.1245/s10434-021-09605-8

Haas, R. L., Delaney, T. F., O'Sullivan, B., Keus, R. B., Le Pechoux, C., Olmi, P., . . . Wang, D. (2012). Radiotherapy for management of extremity soft tissue sarcomas: why, when, and where? International Journal of Radiation Oncology, Biology, Physics, 84(3), 572-580. https://doi.org/10.1016/j.ijrobp.2012.01.062

Igaki, H., Tokuuye, K., Okumura, T., Sugahara, S., Kagei, K., Hata, M., . . . Akine, Y. (2004). Clinical results of proton beam therapy for skull base chordoma. International Journal of Radiation Oncology, Biology, Physics, 60(4), 1120-1126. https://doi.org/10.1016/j.ijrobp.2004.05.064

Igarashi, K., Yamamoto, N., Shirai, T., Hayashi, K., Nishida, H., Kimura, H., . . . Tsuchiya, H. (2014). The long-term outcome following the use of frozen autograft treated with liquid nitrogen in the management of bone and soft-tissue sarcomas. The bone & joint journal, 96-B(4), 555-561. https://doi.org/10.1302/0301-620X.96B4.32629

ISG, & SSG. (2002). An italian - scandinavian treatment protocol for metastatic and pelvic osteosarcoma (ISG/SSG II). Bologna; Lund: Italian sarcoma group (ISG) & Scandinavian sarcoma group and oncologic center (SSG).

Issels, R., & Lindner, L. H. (2016). Regional hyperthermia for high-risk soft tissue sarcoma treatment: present status and next questions. Current Opinion in Oncology, 28(5), 447-452.

Issels, R. D., Lindner, L. H., Verweij, J., Wust, P., Reichardt, P., Schem, B. C., . . . European Society for Hyperthermic, O. (2010). Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncology, 11(6), 561-570.

Jebsen, N. L., Bruland, Ø. S., Eriksson, M., Engellau, J., Turesson, I., Folin, A., . . . Hall, K. S. (2011). Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall. International Journal of Radiation Oncology, Biology, Physics, 81(5), 1359-1366. https://doi.org/10.1016/j.ijrobp.2010.07.037

Jebsen, N. L., Trovik, C. S., Bauer, H. C., Rydholm, A., Monge, O. R., Hall, K. S., . . . Bruland, O. S. (2008). Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study. International Journal of Radiation Oncology, Biology, Physics, 71(4), 1196-1203.

Jian, B. J., Bloch, O. G., Yang, I., Han, S. J., Aranda, D., Tihan, T., & Parsa, A. T. (2010). Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma. Journal of Neuro-Oncology, 98(1), 101-108.

Jingu, K., Tsujii, H., Mizoe, J. E., Hasegawa, A., Bessho, H., Takagi, R., . . . Organizing Committee for the Working Group for Head-and-Neck, C. (2012). Carbon ion radiation therapy improves the prognosis of unresectable adult bone and soft-tissue sarcoma of the head and neck. International Journal of Radiation Oncology, Biology, Physics, 82(5), 2125-2131.

Joensuu, H. (2008). Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Human Pathology, 39(10), 1411-1419.

Joensuu, H., Eriksson, M., Collan, J., Balk, M. H., Leyvraz, S., & Montemurro, M. (2015). Radiotherapy for GIST progressing during or after tyrosine kinase inhibitor therapy: A prospective study. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 116(2), 233-238. https://doi.org/10.1016/j.radonc.2015.07.025

Joensuu, H., Eriksson, M., Sundby Hall, K., Hartmann, J. T., Pink, D., Schutte, J., . . . Reichardt, P. (2012a). One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA, 307(12), 1265-1272. https://doi.org/10.1001/jama.2012.347

Joensuu, H., Eriksson, M., Sundby Hall, K., Reichardt, A., Hartmann, J. T., Pink, D., . . . Reichardt, P. (2016). Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial. Journal of Clinical Oncology, 34(3), 244-250.

Joensuu, H., Eriksson, M., Sundby Hall, K., Reichardt, A., Hermes, B., Schütte, J., . . . Reichardt, P. (2020). Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-up. JAMA oncology, 6(8), 1241-1246. https://doi.org/10.1001/jamaoncol.2020.2091

Joensuu, H., Vehtari, A., Riihimaki, J., Nishida, T., Steigen, S. E., Brabec, P., . . . Rutkowski, P. (2012b). Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncology, 13(3), 265-274. https://doi.org/10.1016/s1470-2045(11)70299-6

Joensuu, H., Wardelmann, E., Eriksson, M., Reichardt, A., Hall, K. S., Schütte, J., . . . Reichardt, P. (2023). KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial. Clinical cancer research : an official journal of the American Association for Cancer Research, 29(17), 3313-3319. https://doi.org/10.1158/1078-0432.Ccr-22-3980

Joensuu, H., Wardelmann, E., Sihto, H., Eriksson, M., Sundby Hall, K., Reichardt, A., . . . Reichardt, P. (2017). Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial. JAMA oncology, 3(5), 602-609. https://doi.org/10.1001/jamaoncol.2016.5751

Jones, R. L., Serrano, C., von Mehren, M., George, S., Heinrich, M. C., Kang, Y. K., . . . Bauer, S. (2021). Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial. European Journal of Cancer, 145, 132-142. https://doi.org/10.1016/j.ejca.2020.12.008

Jordhøy, M. S., Fayers, P., Loge, J. H., Ahlner-Elmqvist, M., & Kaasa, S. (2001). Quality of life in palliative cancer care: results from a cluster randomized trial. Journal of Clinical Oncology, 19(18), 3884-3894.

Judson, I., Verweij, J., Gelderblom, H., Hartmann, J. T., Schöffski, P., Blay, J. Y., . . . van der Graaf, W. T. (2014). Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncology, 15(4), 415-423. https://doi.org/10.1016/s1470-2045(14)70063-4

Kamada, T., Tsujii, H., Tsuji, H., Yanagi, T., Mizoe, J. E., Miyamoto, T., . . . Working Group for the Bone Soft Tissue Sarcomas. (2002). Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. Journal of Clinical Oncology, 20(22), 4466-4471.

Kang, Y. K., Ryu, M. H., Yoo, C., Ryoo, B. Y., Kim, H. J., Lee, J. J., . . . Demetri, G. D. (2013). Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial. Lancet Oncology, 14(12), 1175-1182. https://doi.org/10.1016/s1470-2045(13)70453-4

Kepka, L., DeLaney, T. F., Suit, H. D., & Goldberg, S. I. (2005). Results of radiation therapy for unresected soft-tissue sarcomas. International Journal of Radiation Oncology, Biology, Physics, 63(3), 852-859.

Kinge, B., Tranheim, R. S., & Eide, N. A. (2004). Retinoblastom--arvelig øyekreft hos barn. Tidsskrift for den Norske Legeforening, 124(2), 183-185.

Koch, R., Gelderblom, H., Haveman, L., Brichard, B., Jürgens, H., Cyprova, S., . . . Dirksen, U. (2022). High-Dose Treosulfan and Melphalan as Consolidation Therapy Versus Standard Therapy for High-Risk (Metastatic) Ewing Sarcoma. Journal of Clinical Oncology, 40(21), 2307-2320. https://doi.org/10.1200/jco.21.01942

Koontz, B. F., Clough, R. W., & Halperin, E. C. (2006). Palliative radiation therapy for metastatic Ewing sarcoma. Cancer, 106(8), 1790-1793.

Kransdorf, M. J. (2009). Society of skeletal radiology 2008 annual meeting. Skeletal Radiology, 38(1), 97-100.

Kransdorf, M. J., & Murphey, M. D. (2000). Radiologic evaluation of soft-tissue masses: a current perspective. AJR. American journal of roentgenology, 175(3), 575-587.

Kransdorf, M. J., & Murphey, M. D. (2006). Imaging of soft tissue tumors (2. utg.). Philadelphia, Pa.: Lippincott Williams & Wilkins.

Kubo, T., Furuta, T., Johan, M. P., & Ochi, M. (2016). Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis. European Journal of Cancer, 58, 104-111.

Ladenstein, R., Pötschger, U., Le Deley, M. C., Whelan, J., Paulussen, M., Oberlin, O., . . . Jürgens, H. (2010). Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. Journal of Clinical Oncology, 28(20), 3284-3291. https://doi.org/10.1200/jco.2009.22.9864

Lagrange, J. L., Ramaioli, A., Chateau, M. C., Marchal, C., Resbeut, M., Richaud, P., . . . Coindre, J. M. (2000). Sarcoma after radiation therapy: retrospective multiinstitutional study of 80 histologically confirmed cases. Radiation Therapist and Pathologist Groups of the Federation Nationale des Centres de Lutte Contre le Cancer. Radiology, 216(1), 197-205.

Lakkaraju, A., Sinha, R., Garikipati, R., Edward, S., & Robinson, P. (2009). Ultrasound for initial evaluation and triage of clinically suspicious soft-tissue masses. Clinical Radiology, 64(6), 615-621. https://doi.org/10.1016/j.crad.2009.01.012

Lansu, J., Bovée, J., Braam, P., van Boven, H., Flucke, U., Bonenkamp, J. J., . . . Haas, R. L. (2021). Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial. JAMA oncology, 7(1), e205865. https://doi.org/10.1001/jamaoncol.2020.5865

Le Cesne, A., Antoine, E., Spielmann, M., Le Chevalier, T., Brain, E., Toussaint, C., . . . et al. (1995). High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas. Journal of Clinical Oncology, 13(7), 1600-1608. https://doi.org/10.1200/jco.1995.13.7.1600

Le Cesne, A., Blay, J. Y., Judson, I., Van, O. A., Verweij, J., Radford, J., . . . Nielsen, O. S. (2005). Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial. Journal of Clinical Oncology, 23(3), 576-584.

Le Cesne, A., Ray-Coquard, I., Bui, B. N., Adenis, A., Rios, M., Bertucci, F., . . . Blay, J. Y. (2010). Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial. Lancet Oncology, 11(10), 942-949. https://doi.org/10.1016/s1470-2045(10)70222-9

Lee, A. Y., Rickles, F. R., Julian, J. A., Gent, M., Baker, R. I., Bowden, C., . . . Levine, M. N. (2005a). Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. Journal of Clinical Oncology, 23(10), 2123-2129.

Lee, C. T., Bilton, S. D., Famiglietti, R. M., Riley, B. A., Mahajan, A., Chang, E. L., . . . Smith, A. R. (2005b). Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? International Journal of Radiation Oncology, Biology, Physics, 63(2), 362-372. https://doi.org/10.1016/j.ijrobp.2005.01.060

Levernes, S., & Johannessen, D. C. (2003). Volum og doser ved strålebehandling: definisjoner, retningslinjer for bruk, dokumentasjon og rapportering (StrålevernRapport 2003:12). Østerås: Statens Strålevern. Hentet fra https://dsa.no/publikasjoner/stralevernrapport-12-2003-volum-og-doser-ved-stralebehandling/straalevernrapport-2003-12-volum-og-doser-ved-straalebehandling-definisjoner-retningslinjer-dokumentasjon-rapportering.pdf

Lewis, J. J., Leung, D., Woodruff, J. M., & Brennan, M. F. (1998). Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Annals of Surgery, 228(3), 355-365.

Li, F. P., & Fraumeni, J. F., Jr. (1969). Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Annals of Internal Medicine, 71(4), 747-752.

Li, G. Z., Fairweather, M., Wang, J., Orgill, D. P., Bertagnolli, M. M., & Raut, C. P. (2017). Cutaneous Radiation-associated Breast Angiosarcoma: Radicality of Surgery Impacts Survival. Annals of Surgery, 265(4), 814-820. https://doi.org/10.1097/sla.0000000000001753

Li, Y. J., Dai, Y. L., Cheng, Y. S., Zhang, W. B., & Tu, C. Q. (2016). Positron emission tomography (18)F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: A meta-analysis. European Journal of Surgical Oncology, 42(8), 1103-1114. https://doi.org/10.1016/j.ejso.2016.04.056

Lim, H. J., Johnny Ong, C. A., Tan, J. W., & Ching Teo, M. C. (2019). Utility of positron emission tomography/computed tomography (PET/CT) imaging in the evaluation of sarcomas: A systematic review. Critical Reviews in Oncology/Hematology, 143, 1-13. https://doi.org/10.1016/j.critrevonc.2019.07.002

Liu, F., Zhang, Q., Zhou, D., & Dong, J. (2019). Effectiveness of (18)F-FDG PET/CT in the diagnosis and staging of osteosarcoma: a meta-analysis of 26 studies. BMC Cancer, 19(1), 323. https://doi.org/10.1186/s12885-019-5488-5

Liu, J., Hudkins, P. G., Swee, R. G., & Unni, K. K. (1987). Bone sarcomas associated with Ollier's disease. Cancer, 59(7), 1376-1385.

Longhi, A., Paioli, A., Palmerini, E., Cesari, M., Abate, M. E., Setola, E., . . . Boye, K. (2019). Pazopanib in relapsed osteosarcoma patients: report on 15 cases. Acta Oncologica, 58(1), 124-128. https://doi.org/10.1080/0284186x.2018.1503714

Luksch, R., Tienghi, A., Hall, K. S., Fagioli, F., Picci, P., Barbieri, E., . . . Ferrari, S. (2012). Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation. Annals of oncology, 23(11), 2970-2976. https://doi.org/10.1093/annonc/mds117

Ma, L. D., McCarthy, E. F., Bluemke, D. A., & Frassica, F. J. (1998). Differentiation of benign from malignant musculoskeletal lesions using MR imaging: pitfalls in MR evaluation of lesions with a cystic appearance. AJR. American journal of roentgenology, 170(5), 1251-1258.

Macpherson, R. E., Pratap, S., Tyrrell, H., Khonsari, M., Wilson, S., Gibbons, M., . . . Hassan, A. B. (2018). Retrospective audit of 957 consecutive (18)F-FDG PET-CT scans compared to CT and MRI in 493 patients with different histological subtypes of bone and soft tissue sarcoma. Clinical sarcoma research, 8, 9. https://doi.org/10.1186/s13569-018-0095-9

Malkin, D., Jolly, K. W., Barbier, N., Look, A. T., Friend, S. H., Gebhardt, M. C., . . . Strong, L. C. (1992). Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. New England Journal of Medicine, 326(20), 1309-1315.

Mankin, H. J., Lange, T. A., & Spanier, S. S. (1982). The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. The Journal of bone and joint surgery. American volume, 64(8), 1121-1127.

Marina, N. M., Smeland, S., Bielack, S. S., Bernstein, M., Jovic, G., Krailo, M. D., . . . Whelan, J. S. (2016). Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Lancet Oncology, 17(10), 1396-1408.

Markhede, G., & Stener, B. (1981). Function after removal of various hip and thigh muscles for extirpation of tumors. Acta Orthopaedica Scandinavica, 52(4), 373-395.

Marks, L. B., Yorke, E. D., Jackson, A., Ten Haken, R. K., Constine, L. S., Eisbruch, A., . . . Deasy, J. O. (2010). Use of normal tissue complication probability models in the clinic. International Journal of Radiation Oncology, Biology, Physics, 76(3 Suppl), S10-19. https://doi.org/10.1016/j.ijrobp.2009.07.1754

Menu-Branthomme, A., Rubino, C., Shamsaldin, A., Hawkins, M. M., Grimaud, E., Dondon, M. G., . . . de Vathaire, F. (2004). Radiation dose, chemotherapy and risk of soft tissue sarcoma after solid tumours during childhood. International Journal of Cancer, 110(1), 87-93.

Meyers, P. A., Schwartz, C. L., Krailo, M. D., Healey, J. H., Bernstein, M. L., Betcher, D., . . . Children's Oncology, G. (2008). Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. Journal of Clinical Oncology, 26(4), 633-638.

Miettinen, M., & Lasota, J. (2006). Gastrointestinal stromal tumors: pathology and prognosis at different sites. Seminars in Diagnostic Pathology, 23(2), 70-83. https://doi.org/10.1053/j.semdp.2006.09.001

Milano, M. T., Constine, L. S., & Okunieff, P. (2007). Normal tissue tolerance dose metrics for radiation therapy of major organs. Seminars in Radiation Oncology, 17(2), 131-140.

Miller, T. T. (2008). Bone tumors and tumorlike conditions: analysis with conventional radiography. Radiology, 246(3), 662-674.

Mir, O., Cropet, C., Toulmonde, M., Cesne, A. L., Molimard, M., Bompas, E., . . . Pazogist study group of the French Sarcoma Groupe-Groupe d'Etude des Tumeurs Osseuses. (2016). Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial. Lancet Oncology, 17(5), 632-641. https://doi.org/10.1016/S1470-2045(16)00075-9

Miralbell, R., Lomax, A., Cella, L., & Schneider, U. (2002). Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. International Journal of Radiation Oncology, Biology, Physics, 54(3), 824-829.

Mizumoto, M., Murayama, S., Akimoto, T., Demizu, Y., Fukushima, T., Ishida, Y., . . . Sakurai, H. (2018). Preliminary results of proton radiotherapy for pediatric rhabdomyosarcoma: a multi-institutional study in Japan. Cancer medicine, 7(5), 1870-1874. https://doi.org/10.1002/cam4.1464

Morgan, E. A., Kozono, D. E., Wang, Q., Mery, C. M., Butrynski, J. E., Baldini, E. H., . . . Raut, C. P. (2012). Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy. Annals of Surgical Oncology, 19(12), 3801-3808. https://doi.org/10.1245/s10434-012-2563-4

Moser, R. P., Jr., & Madewell, J. E. (1987). An approach to primary bone tumors. Radiologic Clinics of North America, 25(6), 1049-1093.

Moulton, J. S., Blebea, J. S., Dunco, D. M., Braley, S. E., Bisset, G. S., III, & Emery, K. H. (1995). MR imaging of soft-tissue masses: diagnostic efficacy and value of distinguishing between benign and malignant lesions. AJR. American journal of roentgenology, 164(5), 1191-1199.

Mucciarini, C., Rossi, G., Bertolini, F., Valli, R., Cirilli, C., Rashid, I., . . . Federico, M. (2007). Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study. BMC Cancer, 7, 230. https://doi.org/10.1186/1471-2407-7-230

Murray, E. M., Werner, D., Greeff, E. A., & Taylor, D. A. (1999). Postradiation sarcomas: 20 cases and a literature review. International Journal of Radiation Oncology, Biology, Physics, 45(4), 951-961.

NCCN. (2024). Bone Cancer (NCCN Guidelines Version 1.2024). Plymouth Meeting, PA: National Comprehensive Cancer Network. Hentet fra https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1418

Noel, G., Feuvret, L., Calugaru, V., Dhermain, F., Mammar, H., Haie-Meder, C., . . . Mazeron, J. J. (2005). Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams. Acta Oncologica, 44(7), 700-708. https://doi.org/10.1080/02841860500326257

Noel, G., Habrand, J. L., Jauffret, E., de Crevoisier, R., Dederke, S., Mammar, H., . . . Mazeron, J. J. (2003). Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure. Strahlentherapie und Onkologie, 179(4), 241-248. https://doi.org/10.1007/s00066-003-1065-5

Nordal, R. R. (1998). Uterine sarcomas in Norway 1956-1992: an epidemiological and clinicopathological study (doktorgrad). Oslo: Faculty of Medicine, University of Oslo.

O'Sullivan, B., Davis, A. M., Turcotte, R., Bell, R., Catton, C., Chabot, P., . . . Zee, B. (2002). Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet, 359(9325), 2235-2241.

O'Sullivan, B., Wylie, J., Catton, C., Gutierrez, E., Swallow, C. J., Wunder, J., . . . Bell, R. (1999). The local management of soft tissue sarcoma. Seminars in Radiation Oncology, 9(4), 328-348.

Oberlin, O., Rey, A., Desfachelles, A. S., Philip, T., Plantaz, D., Schmitt, C., . . . Michon, J. (2006). Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: a study by the Société Française des Cancers de l'Enfant. Journal of Clinical Oncology, 24(24), 3997-4002. https://doi.org/10.1200/jco.2006.05.7059

Palmerini, E., Colangeli, M., Nanni, C., Fanti, S., Marchesi, E., Paioli, A., . . . Ferrari, S. (2017). The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas. European journal of nuclear medicine and molecular imaging, 44(2), 215-223. https://doi.org/10.1007/s00259-016-3509-z

Parker, W. H., Fu, Y. S., & Berek, J. S. (1994). Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstetrics and Gynecology, 83(3), 414-418.

Pasquali, S., Pizzamiglio, S., Touati, N., Litiere, S., Marreaud, S., Kasper, B., . . . Gronchi, A. (2019). The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial. European Journal of Cancer, 109, 51-60. https://doi.org/10.1016/j.ejca.2018.12.009

Patel, D. B., & Matcuk, G. R., Jr. (2018). Imaging of soft tissue sarcomas. Chinese clinical oncology, 7(4), 35. https://doi.org/10.21037/cco.2018.07.06

Pautier, P., Italiano, A., Piperno-Neumann, S., Chevreau, C., Penel, N., Firmin, N., . . . Duffaud, F. (2022). Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial. Lancet Oncology, 23(8), 1044-1054. https://doi.org/10.1016/s1470-2045(22)00380-1

Penel, N., Bui, B. N., Bay, J. O., Cupissol, D., Ray-Coquard, I., Piperno-Neumann, S., . . . Blay, J. Y. (2008). Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. Journal of Clinical Oncology, 26(32), 5269-5274.

Pervaiz, N., Colterjohn, N., Farrokhyar, F., Tozer, R., Figueredo, A., & Ghert, M. (2008). A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer, 113(3), 573-581.

Petasnick, J. P., Turner, D. A., Charters, J. R., Gitelis, S., & Zacharias, C. E. (1986). Soft-tissue masses of the locomotor system: comparison of MR imaging with CT. Radiology, 160(1), 125-133.

Pisters, P. W., O'Sullivan, B., & Maki, R. G. (2007). Evidence-based recommendations for local therapy for soft tissue sarcomas. Journal of Clinical Oncology, 25(8), 1003-1008.

Pisters, P. W. T. (2002). Retroperitoneal sarcomas. I: R. E. Pollock (red.), Soft tissue sarcomas (s. 180-188). Hamilton: Decker.

Prasad, S. A., & Pryor, J. A. (2008). Physiotherapy for respiratory and cardiac problems: adults and paediatrics. Edinburgh: Churchill Livingstone Elsevier.

Rakheja, R., Makis, W., Skamene, S., Nahal, A., Brimo, F., Azoulay, L., . . . Hickeson, M. (2012). Correlating metabolic activity on 18F-FDG PET/CT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients. AJR. American journal of roentgenology, 198(6), 1409-1416. https://doi.org/10.2214/AJR.11.7560

Riedel, R. F., Larrier, N., Dodd, L., Kirsch, D., Martinez, S., & Brigman, B. E. (2009). The clinical management of chondrosarcoma. Current Treatment Options in Oncology, 10(1-2), 94-106.

Roberge, D., Vakilian, S., Alabed, Y. Z., Turcotte, R. E., Freeman, C. R., & Hickeson, M. (2012). FDG PET/CT in Initial Staging of Adult Soft-Tissue Sarcoma. Sarcoma, 2012, 960194. https://doi.org/10.1155/2012/960194

Robertson, E. G., & Baxter, G. (2011). Tumour seeding following percutaneous needle biopsy: the real story! Clinical Radiology, 66(11), 1007-1014. https://doi.org/10.1016/j.crad.2011.05.012

Rombi, B., DeLaney, T. F., MacDonald, S. M., Huang, M. S., Ebb, D. H., Liebsch, N. J., . . . Yock, T. I. (2012). Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes. International Journal of Radiation Oncology, Biology, Physics, 82(3), 1142-1148. https://doi.org/10.1016/j.ijrobp.2011.03.038

Rosenberg, A. E., Nielsen, G. P., Keel, S. B., Renard, L. G., Fitzek, M. M., Munzenrider, J. E., & Liebsch, N. J. (1999). Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. The American journal of surgical pathology, 23(11), 1370-1378.

Rowbotham, E., Bhuva, S., Gupta, H., & Robinson, P. (2012). Assessment of referrals into the soft tissue sarcoma service: evaluation of imaging early in the pathway process. Sarcoma, 2012, 781723. https://doi.org/10.1155/2012/781723

Rydholm, A. (1998). Improving the management of soft tissue sarcoma. Diagnosis and treatment should be given in specialist centres. BMJ, 317(7151), 93-94.

Salunke, A. A., Chen, Y., Tan, J. H., Chen, X., Khin, L. W., & Puhaindran, M. E. (2014). Does a pathological fracture affect the prognosis in patients with osteosarcoma of the extremities? : a systematic review and meta-analysis. The bone & joint journal, 96-B(10), 1396-1403. https://doi.org/10.1302/0301-620X.96B10.34370

Sambri, A., Bianchi, G., Longhi, A., Righi, A., Donati, D. M., Nanni, C., . . . Errani, C. (2019). The role of 18F-FDG PET/CT in soft tissue sarcoma. Nuclear Medicine Communications, 40(6), 626-631. https://doi.org/10.1097/mnm.0000000000001002

Schmidt-Braekling, T., Streitbuerger, A., Gosheger, G., Boettner, F., Nottrott, M., Ahrens, H., . . . Hardes, J. (2017). Silver-coated megaprostheses: review of the literature. European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 27(4), 483-489. https://doi.org/10.1007/s00590-017-1933-9

Schwartz, H. S., Zimmerman, N. B., Simon, M. A., Wroble, R. R., Millar, E. A., & Bonfiglio, M. (1987). The malignant potential of enchondromatosis. The Journal of bone and joint surgery. American volume, 69(2), 269-274.

Schöffski, P., Chawla, S., Maki, R. G., Italiano, A., Gelderblom, H., Choy, E., . . . Patel, S. R. (2016). Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial. Lancet, 387(10028), 1629-1637. https://doi.org/10.1016/s0140-6736(15)01283-0

Schöffski, P., Mir, O., Kasper, B., Papai, Z., Blay, J. Y., Italiano, A., . . . Gelderblom, H. (2020). Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'. European Journal of Cancer, 134, 62-74. https://doi.org/10.1016/j.ejca.2020.04.021

Seddon, B., Strauss, S. J., Whelan, J., Leahy, M., Woll, P. J., Cowie, F., . . . Beare, S. (2017). Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial. Lancet Oncology, 18(10), 1397-1410. https://doi.org/10.1016/s1470-2045(17)30622-8

Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma. (2021-2034). [pågående studie]. (NCT04776525). Hentet fra https://clinicaltrials.gov/ct2/show/NCT04776525

Sleijfer, S., Ray-Coquard, I., Papai, Z., Le Cesne, A., Scurr, M., Schoffski, P., . . . Blay, J. Y. (2009). Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043). Journal of Clinical Oncology, 27(19), 3126-3132. https://doi.org/10.1200/jco.2008.21.3223

Smith, H. G., Cartwright, J., Wilkinson, M. J., Strauss, D. C., Thomas, J. M., & Hayes, A. J. (2015). Isolated Limb Perfusion with Melphalan and Tumour Necrosis Factor alpha for In-Transit Melanoma and Soft Tissue Sarcoma. Annals of Surgical Oncology, 22(Suppl 3), S356-361.

Smith, L. M., & Donaldson, S. S. (1991). Incidence and management of secondary malignancies in patients with retinoblastoma and Ewing's sarcoma. Oncology (Williston Park, N.Y.), 5(5), 135-141; discussion 142.

Smith, M. J., Ridgway, P. F., Catton, C. N., Cannell, A. J., O'Sullivan, B., Mikula, L. A., . . . Swallow, C. J. (2014). Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: long-term results of a prospective trial. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 110(1), 165-171. https://doi.org/10.1016/j.radonc.2013.10.041

Souba, W. W., McKenna, R. J., Jr., Meis, J., Benjamin, R., Raymond, A. K., & Mountain, C. F. (1986). Radiation-induced sarcomas of the chest wall. Cancer, 57(3), 610-615.

SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST. (2016-2022). [pågående studie]. (NCT02924714). Hentet fra https://clinicaltrials.gov/ct2/show/NCT02924714

Stacchiotti, S., Tortoreto, M., Bozzi, F., Tamborini, E., Morosi, C., Messina, A., . . . Casali, P. G. (2013). Dacarbazine in solitary fibrous tumor: a case series analysis and preclinical evidence vis-a-vis temozolomide and antiangiogenics. Clinical cancer research : an official journal of the American Association for Cancer Research, 19(18), 5192-5201. https://doi.org/10.1158/1078-0432.Ccr-13-0776

Stanborough, R., Demertzis, J. L., Wessell, D. E., Lenchik, L., Ahlawat, S., Baker, J. C., . . . Beaman, F. D. (2022). ACR Appropriateness Criteria® Malignant or Aggressive Primary Musculoskeletal Tumor-Staging and Surveillance: 2022 Update. Journal of the American College of Radiology : JACR, 19(11 suppl), S374-s389. https://doi.org/10.1016/j.jacr.2022.09.015

Stoeckle, E., Coindre, J. M., Bonvalot, S., Kantor, G., Terrier, P., Bonichon, F., . . . French Federation of Cancer Centers Sarcoma, G. (2001). Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer, 92(2), 359-368.

Stoldt, H. S., & Geraghty, J. G. (1999). Surgical principles in the management of soft tissue sarcomas. I: I. Taylor & C. D. Johnson (red.), Recent advances in surgery (s. 47-61). London: Royal Society of Medicine Press.

Strander, H., Bauer, H. C., Brosjö, O., Fernberg, J. O., Kreicbergs, A., Nilsonne, U., . . . Söderlund, V. (1995). Long-term adjuvant interferon treatment of human osteosarcoma. A pilot study. Acta Oncologica, 34(6), 877-880.

Strander, H., & Einhorn, S. (1977). Effect of human leukocyte interferon on the growth of human osteosarcoma cells in tissue culture. International Journal of Cancer, 19(4), 468-473.

Strauss, S. J., Frezza, A. M., Abecassis, N., Bajpai, J., Bauer, S., Biagini, R., . . . Stacchiotti, S. (2021). Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of oncology, 32(12), 1520-1536. https://doi.org/10.1016/j.annonc.2021.08.1995

Suit, H., Kooy, H., Trofimov, A., Farr, J., Munzenrider, J., DeLaney, T., . . . Paganetti, H. (2008). Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 86(2), 148-153. https://doi.org/10.1016/j.radonc.2007.12.024

Surgery With Our Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma (STRASS2). (2019-2028). [pågående studie]. (NCT04031677). Hentet fra https://clinicaltrials.gov/ct2/show/NCT04031677

Swallow, C. J., Strauss, D. C., Bonvalot, S., Rutkowski, P., Desai, A., Gladdy, R. A., . . . Gronchi, A. (2021). Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group. Annals of Surgical Oncology, 28(12), 7873-7888. https://doi.org/10.1245/s10434-021-09654-z

Swanson, E. L., Indelicato, D. J., Louis, D., Flampouri, S., Li, Z., Morris, C. G., . . . Slopsema, R. (2012). Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas. International Journal of Radiation Oncology, Biology, Physics, 83(5), 1549-1557. https://doi.org/10.1016/j.ijrobp.2011.10.014

Tangvik, R. J., Tell, G. S., Guttormsen, A. B., Eisman, J. A., Henriksen, A., Nilsen, R. M., & Ranhoff, A. H. (2015). Nutritional risk profile in a university hospital population. Clinical Nutrition, 34(4), 705-711.

Tawbi, H. A., Burgess, M., Bolejack, V., Van Tine, B. A., Schuetze, S. M., Hu, J., . . . Patel, S. (2017). Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncology, 18(11), 1493-1501. https://doi.org/10.1016/s1470-2045(17)30624-1

Tehranzadeh, J., Mnaymneh, W., Ghavam, C., Morillo, G., & Murphy, B. J. (1989). Comparison of CT and MR imaging in musculoskeletal neoplasms. Journal of Computer Assisted Tomography, 13(3), 466-472.

Thomas, H., & Timmermann, B. (2020). Paediatric proton therapy. The British journal of radiology, 93(1107), 20190601. https://doi.org/10.1259/bjr.20190601

Thoresen, S. O. (1992). Li-Fraumeni-syndromet og p53-genet. Tidsskrift for den Norske Legeforening, 112(7), 887-889.

Toguchida, J., Yamaguchi, T., Dayton, S. H., Beauchamp, R. L., Herrera, G. E., Ishizaki, K., . . . Sasaki, M. S. (1992). Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. New England Journal of Medicine, 326(20), 1301-1308.

Toulmonde, M., Bonvalot, S., Méeus, P., Stoeckle, E., Riou, O., Isambert, N., . . . Italiano, A. (2014). Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group. Annals of oncology, 25(3), 735-742. https://doi.org/10.1093/annonc/mdt577

Travis, L. B., Rabkin, C. S., Brown, L. M., Allan, J. M., Alter, B. P., Ambrosone, C. B., . . . Greene, M. H. (2006). Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations. Journal of the National Cancer Institute, 98(1), 15-25.

Trovik, C., Bauer, H. C. F., Styring, E., Sundby Hall, K., Vult Von Steyern, F., Eriksson, S., . . . Alvegard, T. A. (2017). The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma. Acta orthopaedica, 88(3), 341-347. https://doi.org/10.1080/17453674.2017.1293441

Trovik, C. S., Bauer, H. C., Berlin, O., Tukiainen, E., Erlanson, M., Gustafson, P., . . . Wahlstrom, O. (2001). Local recurrence of deep-seated, high-grade, soft tissue sarcoma: 459 patients from the Scandinavian Sarcoma Group Register. Acta Orthopaedica Scandinavica, 72(2), 160-166.

Trovik, L. H., Ovrebo, K., Almquist, M., Haugland, H. K., Rissler, P., Eide, J., . . . Jebsen, N. L. (2014). Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients. Acta Oncologica, 53(9), 1165-1172.

Tsuchiya, T., Sekine, K., Hinohara, S., Namiki, T., Nobori, T., & Kaneko, Y. (2000). Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma. Cancer Genetics and Cytogenetics, 120(2), 91-98.

Uhl, M., Edler, L., Jensen, A. D., Habl, G., Oelmann, J., Röder, F., . . . Herfarth, K. (2014). Randomized phase II trial of hypofractionated proton versus carbon ion radiation therapy in patients with sacrococcygeal chordoma-the ISAC trial protocol. Radiation oncology, 9, 100. https://doi.org/10.1186/1748-717X-9-100

van der Graaf, W. T., Blay, J. Y., Chawla, S. P., Kim, D. W., Bui-Nguyen, B., Casali, P. G., . . . Hohenberger, P. (2012). Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet, 379(9829), 1879-1886. https://doi.org/10.1016/s0140-6736(12)60651-5

Van Glabbeke, M., Verweij, J., Judson, I., & Nielsen, O. S. (2002). Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas. European Journal of Cancer, 38(4), 543-549. https://doi.org/10.1016/s0959-8049(01)00398-7

van Houdt, W. J., NS, I. J., Marjolein Schrijver, A., Huis In 't Veld, E., Thway, K., Jones, R. L., . . . Smith, M. J. F. (2021). Oncological Outcome After Diagnostic Biopsies in Gastrointestinal Stromal Tumors: A Retrospective Cohort Study. Annals of Surgery, 274(6), e1093-e1098. https://doi.org/10.1097/sla.0000000000003744

van Houdt, W. J., Raut, C. P., Bonvalot, S., Swallow, C. J., Haas, R., & Gronchi, A. (2019). New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaboration. Current opinion in oncology, 31(4), 310-316. https://doi.org/10.1097/cco.0000000000000535

van Praag, V. M., Rueten-Budde, A. J., Jeys, L. M., Laitinen, M. K., Pollock, R., Aston, W., . . . Fiocco, M. (2017). A prediction model for treatment decisions in high-grade extremity soft-tissue sarcomas: Personalised sarcoma care (PERSARC). European Journal of Cancer, 83, 313-323. https://doi.org/10.1016/j.ejca.2017.06.032

Van Winkle, P., Angiolillo, A., Krailo, M., Cheung, Y. K., Anderson, B., Davenport, V., . . . Cairo, M. S. (2005). Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience. Pediatric blood & cancer, 44(4), 338-347. https://doi.org/10.1002/pbc.20227

Villano, A. M., Zeymo, A., Chan, K. S., Shara, N., & Al-Refaie, W. B. (2020). Identifying the Minimum Volume Threshold for Retroperitoneal Soft Tissue Sarcoma Resection: Merging National Data with Consensus Expert Opinion. Journal of the American College of Surgeons, 230(1), 151-160.e152. https://doi.org/10.1016/j.jamcollsurg.2019.09.013

Vincenzi, B., Napolitano, A., Fiocco, M., Mir, O., Rutkowski, P., Blay, J. Y., . . . Casali, P. G. (2021). Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study. Clinical cancer research : an official journal of the American Association for Cancer Research, 28(8), 1672–1679. https://doi.org/10.1158/1078-0432.Ccr-21-1665

Wafa, H., Grimer, R. J., Reddy, K., Jeys, L., Abudu, A., Carter, S. R., & Tillman, R. M. (2015). Retrospective evaluation of the incidence of early periprosthetic infection with silver-treated endoprostheses in high-risk patients: case-control study. The bone & joint journal, 97-B(2), 252-257. https://doi.org/10.1302/0301-620X.97B2.34554

Wang, D., Bosch, W., Roberge, D., Finkelstein, S. E., Petersen, I., Haddock, M., . . . DeLaney, T. F. (2011). RTOG sarcoma radiation oncologists reach consensus on gross tumor volume and clinical target volume on computed tomographic images for preoperative radiotherapy of primary soft tissue sarcoma of extremity in Radiation Therapy Oncology Group studies. International Journal of Radiation Oncology, Biology, Physics, 81(4), e525-528. https://doi.org/10.1016/j.ijrobp.2011.04.038

Weatherall, P. T. (1995). Benign and malignant masses. MR imaging differentiation. Magnetic Resonance Imaging Clinics of North America, 3(4), 669-694.

Weber, D. C., Murray, F. R., Correia, D., Bolsi, A., Frei-Welte, M., Pica, A., . . . Bachtiary, B. (2017). Pencil beam scanned protons for the treatment of patients with Ewing sarcoma. Pediatric blood & cancer, 64(12). https://doi.org/10.1002/pbc.26688

Weber, D. C., Trofimov, A. V., Delaney, T. F., & Bortfeld, T. (2004). A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas. International Journal of Radiation Oncology, Biology, Physics, 58(5), 1596-1606. https://doi.org/10.1016/j.ijrobp.2003.11.028

Westra, W. H. H., R. H., Phelps, T. H., & Isacson, C. (red.). (2003). Surgical pathology dissection: an illustrated guide (2. utg.). New York: Springer.

Whelan, J., Le Deley, M. C., Dirksen, U., Le Teuff, G., Brennan, B., Gaspar, N., . . . Oberlin, O. (2018). High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008. Journal of Clinical Oncology, 36(31), 3110-3119. https://doi.org/10.1200/jco.2018.78.2516

WHO Classification of Tumours Editorial Board. (2020). WHO Classification of Tumours of Soft Tissue and Bone (5. utg.). (WHO Classification of Tumours, Volume 3). Geneva: WHO.

Wick, M. R., Siegal, G. P., Unni, K. K., McLeod, R. A., & Greditzer, H. G., III. (1981). Sarcomas of bone complicating osteitis deformans (Paget's disease): fifty years' experience. The American journal of surgical pathology, 5(1), 47-59.

Widhe, B., & Widhe, T. (2000). Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. The Journal of bone and joint surgery. American volume, 82(5), 667-674.

Wilky, B. A., Trucco, M. M., Subhawong, T. K., Florou, V., Park, W., Kwon, D., . . . Trent, J. C. (2019). Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial. Lancet Oncology, 20(6), 837-848. https://doi.org/10.1016/s1470-2045(19)30153-6

Wittekind, C., Compton, C. C., Greene, F. L., & Sobin, L. H. (2002). TNM residual tumor classification revisited. Cancer, 94(9), 2511-2516.

Wolfson, A. H., Benedetto, P. W., Mnaymneh, W., Moffat, F. L., Robinson, D. S., Boyer, C., . . . Markoe, A. M. (1998). Does a radiation dose-response relation exist concerning survival of patients who have soft-tissue sarcomas of the extremities? Radiation dose-response relation for soft-tissue sarcomas. American Journal of Clinical Oncology, 21(3), 270-274.

Woll, P. J., Reichardt, P., Le Cesne, A., Bonvalot, S., Azzarelli, A., Hoekstra, H. J., . . . EORTC Soft Tissue and Bone Sarcoma Group and the NCIC Clinical Trials Group Sarcoma Disease Site Committee. (2012). Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncology, 13(10), 1045-1054.

Yang, J. C., Chang, A. E., Baker, A. R., Sindelar, W. F., Danforth, D. N., Topalian, S. L., . . . Rosenberg, S. A. (1998). Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. Journal of Clinical Oncology, 16(1), 197-203.

Yap, J., Chuba, P. J., Thomas, R., Aref, A., Lucas, D., Severson, R. K., & Hamre, M. (2002). Sarcoma as a second malignancy after treatment for breast cancer. International Journal of Radiation Oncology, Biology, Physics, 52(5), 1231-1237.

Zagars, G. K., & Ballo, M. T. (2003). Significance of dose in postoperative radiotherapy for soft tissue sarcoma. International Journal of Radiation Oncology, Biology, Physics, 56(2), 473-481.

Zaikova, O., Sundby Hall, K., Styring, E., Eriksson, M., Trovik, C. S., Bergh, P., . . . Bauer, H. C. (2015). Referral patterns, treatment and outcome of high-grade malignant bone sarcoma in Scandinavia--SSG Central Register 25 years' experience. Journal of surgical oncology, 112(8), 853-860.

Zalcberg, J. R., Verweij, J., Casali, P. G., Le Cesne, A., Reichardt, P., Blay, J. Y., . . . Australasian Gastrointestinal Trials Group. (2005). Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg. European Journal of Cancer, 41(12), 1751-1757.

Zhou, H., Coffin, C. M., Perkins, S. L., Tripp, S. R., Liew, M., & Viskochil, D. H. (2003). Malignant peripheral nerve sheath tumor: a comparison of grade, immunophenotype, and cell cycle/growth activation marker expression in sporadic and neurofibromatosis 1-related lesions. The American journal of surgical pathology, 27(10), 1337-1345.